Sanofi (SNY) Change in Receivables (2018 - 2025)

Sanofi has disclosed Change in Receivables across 7 years of filings, most recently posting -$1.4 billion for Q4 2025.

• In Q4 2025, Change in Receivables fell 4576.3% year-over-year to -$1.4 billion; the TTM figure through Dec 2025 stood at -$2.7 billion (down 83.17% YoY), while the FY2025 annual figure was -$1.4 billion, down 4516.92% from the prior year.
• Change in Receivables came in at -$1.4 billion for Q4 2025 at Sanofi, down from -$29.9 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of -$29.9 million in Q4 2024 to a low of -$1.4 billion in Q4 2025.
• Average Change in Receivables over 4 years is -$682.4 million, with a median of -$650.3 million recorded in 2023.
• Year-over-year, Change in Receivables jumped 94.11% in 2024 and tumbled 4576.3% in 2025.
• Over 4 years, Change in Receivables stood at -$792.7 million in 2022, then surged by 35.94% to -$507.8 million in 2023, then jumped by 94.11% to -$29.9 million in 2024, then plunged by 4576.3% to -$1.4 billion in 2025.
• Per Business Quant data, the three most recent Change in Receivables figures were -$1.4 billion in Q4 2025, -$29.9 million in Q4 2024, and -$507.8 million in Q4 2023.